Showing 1 - 3 results of 3 for search 'Moritz Thran', query time: 0.03s Refine Results
  1. 1
    Co-administration of an effector antibody enhances the half-life and therapeutic potential of RNA-encoded nanobodies

    Co-administration of an effector antibody enhances the half-life and therapeutic potential of RNA-encoded nanobodies by Moritz Thran, Marion Pönisch, Hillary Danz, Nigel Horscroft, Konstantin Ichtchenko, Saul Tzipori, Charles B. Shoemaker

    Published 2023-09-01
    Get full text
    Article
  2. 2
    Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses

    Optimised Non-Coding Regions of mRNA SARS-CoV-2 Vaccine CV2CoV Improves Homologous and Heterologous Neutralising Antibody Responses by Nicole Roth, Jacob Schön, Donata Hoffmann, Moritz Thran, Andreas Thess, Stefan O. Mueller, Benjamin Petsch, Susanne Rauch

    Published 2022-08-01
    Get full text
    Article
  3. 3
    CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2

    CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2 by Donata Hoffmann, Björn Corleis, Susanne Rauch, Nicole Roth, Janine Mühe, Nico Joel Halwe, Lorenz Ulrich, Charlie Fricke, Jacob Schön, Anna Kraft, Angele Breithaupt, Kerstin Wernike, Anna Michelitsch, Franziska Sick, Claudia Wylezich, Bernd Hoffmann, Moritz Thran, Andreas Thess, Stefan O. Mueller, Thomas C. Mettenleiter, Benjamin Petsch, Anca Dorhoi, Martin Beer

    Published 2021-06-01
    Get full text
    Article

Search Tools: